A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP)NEW YORK, Feb. 18, 2025 ...

COAST Phase 3 trial evaluates superiority and safety of sozinibercept combined with aflibercept in wet AMDCompany confirms topline results for ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Rural Medevac Alliance announced that its local base of operations, Battle Born Medevac 1, is now operational 24/7. Over the ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval for its biosimilar to be completed in the fourth quarter of 2025.

The spot the difference game is an entertaining and interactive puzzle that tests your observation ability. In this age-old ...

As an ageing driver population faces vision challenges when driving in the dark, we take a look at cutting-edge tech designed to improve eyesight and keep people on the road ...

Tech gadgets could help us navigate our golden years. Instead, they're making things worse.

Sociodemographic factors may affect visual acuity outcomes following unilateral pediatric cataract extraction.

Hyperacute outer retinal dysfunction can affect children following a fever, and may include symptoms of bilateral vision loss and disruption of external limiting membrane.